Consequences of replacing EGFR juxtamembrane domain with an unstructured sequence

Scientific Reports

Volumn 2, Issue , 2012, Pages

  He, Lijuan ^a   Hristova, Kalina ^a  

^a Johns Hopkins University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; LIGAND;

ANIMAL; ARTICLE; CELL STRAIN HEK293; CHEMISTRY; CHO CELL; GENE EXPRESSION; GENE VECTOR; GENETICS; HAMSTER; HUMAN; METABOLISM; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN MULTIMERIZATION;

ANIMALS; CHO CELLS; CRICETINAE; EPIDERMAL GROWTH FACTOR; GENE EXPRESSION; GENETIC VECTORS; HEK293 CELLS; HUMANS; LIGANDS; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN MULTIMERIZATION; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 84870823045     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep00854     Document Type: Article

References (46)

1. Wells, A. EGF receptor. International Journal of Biochemistry & Cell Biology 31, 637-643 (1999). (Pubitemid 29248872)
2. Linggi, B. & Carpenter, G. ErbB receptors: new insights on mechanisms and biology. Trends in Cell Biology 16, 649-656 (2006). (Pubitemid 44809890)
3. Grandis, J. R. & Sok, J. C. Signaling through the epidermal growth factor receptor during the development of malignancy. Pharmacology & Therapeutics 102, 37-46 (2004). (Pubitemid 38429984)
4. Drevs, J., Medinger, M., Schmidt-Gerbach, C., Weber, R. & Unger, C. Receptor Tyrosine Kinases: The Main Targets for New Anticancer Therapy. Current Drug Targets 4, 113-121 (2003). (Pubitemid 36559490)
5. Pantaleo, M. A. et al. Molecular imaging and targeted therapies in oncology: New concepts in treatment response assessment. A collection of cases. International Journal of Oncology 33, 443-452 (2008).
6. Schlessinger, J. Cell signaling by receptor tyrosine kinases. Cell 103, 211-225 (2000).
7. Eswarakumar, V. P., Lax, I. & Schlessinger, J. Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev. 16, 139-149 (2005). (Pubitemid 40616112)
8. Schlessinger, J. Common and distinct elements in cellular signaling via EGF and FGF receptors. Science 306, 1506-1507 (2004). (Pubitemid 39564935)
9. Zhang, X. W., Gureasko, J., Shen, K., Cole, P. A. & Kuriyan, J. An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor. Cell 125, 1137-1149 (2006). (Pubitemid 43866200)
10. Burgess, A. W. et al. An open-and-shut case? Recent insights into the activation of EGF/ErbB receptors. Molecular Cell 12, 541-552 (2003). (Pubitemid 37222478)
11. Alvarado, D., Klein, D. E. & Lemmon, M. A. Structural Basis for Negative Cooperativity in Growth Factor Binding to an EGF Receptor. Cell 142, 568-579 (2010).
12. Escher, C., Cymer, F. & Schneider, D. Two GxxxG-Like Motifs Facilitate Promiscuous Interactions of the Human ErbB Transmembrane Domains. J. Mol. Biol. 389, 10-16 (2009).
13. Chen, L., Merzlyakov, M., Cohen, T., Shai, Y. & Hristova, K. Energetics of ErbB1 transmembrane domain dimerization in lipid bilayers. Biophys. J. 96, 4622-4630 (2009).
14. Jura, N. et al. Mechanism for Activation of the EGF Receptor Catalytic Domain by the Juxtamembrane Segment. Cell 137, 1293-1307 (2009).
15. Macdonald-Obermann, J. L. & Pike, L. J. The Intracellular Juxtamembrane Domain of the Epidermal Growth Factor (EGF) Receptor Is Responsible for the Allosteric Regulation of EGF Binding. J. Biol. Chem. 284, 13570-13576 (2009).
16. Thiel, K. W. & Carpenter, G. Epidermal growth factor receptor juxtamembrane region regulates allosteric tyrosine kinase activation. Proceedings of the National Academy of Sciences of the United States of America 104, 19238-19243 (2007).
17. Evers, T. H., van Dongen, E. M. W. M., Faesen, A. C., Meijer, E. W. & Merkx, M. Quantitative understanding of the energy transfer between fluorescent proteins connected via flexible peptide linkers. Biochemistry 45, 13183-13192 (2006). (Pubitemid 44707679)
18. Fanger, B. O., Stephens, J. E. & Staros, J. V. High-Yield Trapping of Egf-Induced Receptor Dimers by Chemical Cross-Linking. FASEB J. 3, 71-75 (1989). (Pubitemid 19042568)
19. Monsonego-Ornan, E., Adar, R., Feferman, T., Segev, O. & Yayon, A. The transmembrane mutation G380R in fibroblast growth factor receptor 3 uncouples ligand-mediated receptor activation from down-regulation. Mol. Cell. Biol. 20, 516-522 (2000). (Pubitemid 30023093)
20. Weiner, D. B., Liu, J., Cohen, J. A., Williams, W. V. & Greene, M. I. A Point Mutation in the Neu Oncogene Mimics Ligand Induction of Receptor Aggregation. Nature 339, 230-231 (1989). (Pubitemid 19126396)
21. Angers, S. et al. Detection of beta(2)-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET). Proceedings of the National Academy of Sciences of the United States of America 97, 3684-3689 (2000). (Pubitemid 30183363)
22. Chen, L., Novicky, L., Merzlyakov, M., Hristov, T. & Hristova, K. Measuring the Energetics of Membrane Protein Dimerization in Mammalian Membranes. J. Am. Chem. Soc. 132, 3628-3635 (2010).
23. Chen, L., Placone, J., Novicky, L. & Hristova, K. The extracellular domain of fibroblast growth factor receptor 3 inhibits ligand-independent dimerization. Science Signaling 3, ra86 (2010).
24. Scott, R. E. Plasma membrane vesiculation: A new technique for isolation of plasma membrane. Science 194, 743-745 (1976).
25. Scott, R. E. & Maercklein, P. B. Plasma-Membrane Vesiculation in 3T3-Cells and Sv3T3 Cells 2 Factors Affecting the Process of Vesiculation. J. Cell Sci. 35, 245-252 (1979). (Pubitemid 9092083)
26. Scott, R. E., Perkins, R. G., Zschunke, M. A., Hoerl, B. J. & Maercklein, P. B. Plasma-Membrane Vesiculation in 3T3-Cells and Sv3T3-Cells 1 Morphological and Biochemical Characterization. J. Cell Sci. 35, 229-243 (1979). (Pubitemid 9092082)
27. Li, E., Placone, J., Merzlyakov, M. & Hristova, K. Quantitative measurements of protein interactions in a crowded cellular environment. Anal. Chem. 80, 5976-5985 (2008).
28. Chang, P. M., Ilangumaran, S., La Rose, J., Chakrabartty, A. & Rottapel, R. Autoinhibition of the Kit receptor tyrosine kinase by the cytosolic juxtamembrane region. Mol. Cell. Biol. 23, 3067-3078 (2003). (Pubitemid 36459222)
29. Griffith, J. et al. The structural basis for autoinhibition of FLT3 by the juxtamembrane domain. Molecular Cell 13, 169-178 (2004). (Pubitemid 38183264)
30. Binns, K. L., Taylor, P. P., Sicheri, F., Pawson, T. & Holland, S. J. Phosphorylation of tyrosine residues in the kinase domain and juxtamembrane region regulates the biological and catalytic activities of eph receptors. Mol. Cell. Biol. 20, 4791-4805 (2000). (Pubitemid 30396126)
31. Mol, C. D. et al. Structure of a c-Kit product complex reveals the basis for kinase transactivation. J. Biol. Chem. 278, 31461-31464 (2003). (Pubitemid 37048320)
32. Wybenga-Groot, L. E. et al. Structural basis for autoinhibition of the EphB2 receptor tyrosine kinase by the unphosphorylated juxtamembrane region. Cell 106, 745-757 (2001). (Pubitemid 32900665)
33. Brewer, M. R. et al. The Juxtamembrane Region of the EGF Receptor Functions as an Activation Domain. Molecular Cell 34, 641-651 (2009).
34. Yang, K. S., Ilagan, M. X. G., Piwnica-Worms, D. & Pike, L. J. Luciferase Fragment Complementation Imaging of Conformational Changes in the Epidermal Growth Factor Receptor. J. Biol. Chem. 284, 7474-7482 (2009).
35. Merzlyakov, M. & Hristova, K. Forster Resonance Energy Transfer Measurements of Transmembrane Helix Dimerization Energetics. Methods in Enzymology: Fluorescence Spectroscopy 450, 107-127 (2008).
36. Macdonald, J. L. & Pike, L. J. Heterogeneity in EGF-binding affinities arises from negative cooperativity in an aggregating system. Proceedings of the National Academy of Sciences of the United States of America 105, 112-117 (2008).
37. Kozer, N. et al. Evidence for extended YFP-EGFR dimers in the absence of ligand on the surface of living cells. Physical Biology 8 (2011).
38. Chung, I. et al. Spatial control of EGF receptor activation by reversible dimerization on living cells. Nature 464, 783-U163 (2010).
39. Yu, X. C., Sharma, K. D., Takahashi, T., Iwamoto, R. & Mekada, E. Ligandindependent dimer formation of epidermal growth factor receptor (EGFR) is a step separable from ligand-induced EGFR signaling. Mol. Biol. Cell 13, 2547-2557 (2002). (Pubitemid 34831354)
40. Moriki, T., Maruyama, H. & Maruyama, I. N. Activation of preformed EGF receptor dimers by ligand-induced rotation of the transmembrane domain. J. Mol. Biol. 311, 1011-1026 (2001). (Pubitemid 32803717)
41. He, L. & Hristova, K. Pathogenic activation of receptor tyrosine kinases in mammalian membranes. J. Mol. Biol. 384, 1130-1142 (2008).
42. Chen, F. H. & Hristova, K. The Physical Basis of FGFR3 Response to fgf1 and fgf2. Biochemistry 50, 8576-8582 (2011).
43. He, L., Wimley, W. C. & Hristova, K. FGFR3 heterodimerization in achondroplasia, the most common form of human dwarfism. J. Biol. Chem. 286, 13272-13281 (2011).
44. He, L. J., Shobnam, N. & Hristova, K. Specific inhibition of a pathogenic receptor tyrosine kinase by its transmembrane domain. Biochimica et Biophysica Acta-Biomembranes 1808, 253-259 (2011).
45. He, L. J., Hoffmann, A. R., Serrano, C., Hristova, K. & Wimley, W. C. High-Throughput Selection of Transmembrane Sequences That Enhance Receptor Tyrosine Kinase Activation. J. Mol. Biol. 412, 43-54 (2011).
46. Del Piccolo, N., Placone, J., He, L., Agudelo, S. C. & Hristova, K. Production of plasma membrane vesicles with chloride salts and their utility as a cell membrane mimetic for biophysical characterization of membrane protein interactions. Anal. Chem. 84, 8650-8655 (2012).